High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis

High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis

Introduction COPD exacerbations are heterogeneous and can be triggered by bacterial, viral, or noninfectious insults. Exacerbations are also heterogeneous in neutrophilic or eosinophilic inflammatory responses. A noninvasive peripheral biomarker of COPD exacerbations characterised by bacterial/neutr...

Full description

Bibliographic Details
Main Authors:	Arindam Chakrabarti, Jordan S. Mar, David F. Choy, Yi Cao, Nisha Rathore, Xiaoying Yang, Gaik W. Tew, Olga Li, Prescott G. Woodruff, Christopher E. Brightling, Michele Grimbaldeston, Stephanie A. Christenson, Mona Bafadhel, Carrie M. Rosenberger
Format:	Article
Language:	English
Published:	European Respiratory Society 2021-08-01
Series:	ERJ Open Research
Online Access:	http://openres.ersjournals.com/content/7/3/00836-2020.full

Similar Items

Lysophosphatidic acid species are associated with exacerbation in chronic obstructive pulmonary disease
by: Qingling Li, et al.
Published: (2021-09-01)

Inhaled glucocorticoids and COPD exacerbations.
by: Brightling, C, et al.
Published: (2015)

Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis.
by: Bafadhel, M, et al.
Published: (2014)

Lung microbiome dynamics in COPD exacerbations
by: Wang, Z, et al.
Published: (2016)

COPD exacerbation severity and frequency is associated with impaired macrophage efferocytosis of eosinophils
by: Eltboli, O, et al.
Published: (2014)

Is it time to give up on "self-management" of COPD exacerbations?
by: Ramakrishnan, S, et al.
Published: (2020)

Blood Eosinophils and outcomes in severe hospitalized exacerbations of COPD
by: Bafadhel, M, et al.
Published: (2016)

Aspergillus fumigatus during stable state and exacerbations of COPD.
by: Bafadhel, M, et al.
Published: (2014)

Benralizumab for the prevention of COPD exacerbations
by: Criner, G, et al.
Published: (2019)

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
by: Bafadhel, M, et al.
Published: (2011)

COPD exacerbations: transforming outcomes through research
by: Hurst, JR, et al.
Published: (2018)

Association Between Pathogens Detected Using Quantitative Polymerase Chain Reaction With Airway Inflammation in COPD at Stable State and Exacerbations.
by: Barker, B, et al.
Published: (2015)

A bronchial gene signature specific for severe COPD that is retained in the nose
by: Jos van Nijnatten, et al.
Published: (2023-11-01)

Renaming COPD exacerbations: the UK respiratory nursing perspective
by: Christine Mwasuku, et al.
Published: (2021-09-01)

Characterising non-eosinophilic COPD
by: Hambleton, K, et al.
Published: (2015)

Building toolkits for COPD exacerbations: lessons from the past and present
by: Sapey, E, et al.
Published: (2019)

Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics
by: Haldar, K, et al.
Published: (2017)

Destination Airway: Tracking Granulocytes in Asthma
by: Christopher E. Brightling
Published: (2014-12-01)

Biological exacerbation clusters demonstrate asthma and COPD overlap with distinct mediator and microbiome profiles
by: Ghebre, M, et al.
Published: (2018)

Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function
by: Bafadhel M, et al.
Published: (2015-06-01)

Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO
by: Camp, J, et al.
Published: (2018)

Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO
by: James Camp, et al.
Published: (2018-09-01)

Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals
by: Singh D, et al.
Published: (2021-11-01)

Neutrophil elastase as a biomarker for bacterial infection in COPD
by: Thulborn, S, et al.
Published: (2019)

Acute exacerbations of COPD
by: W MaxNee
Published: (2003-05-01)

Predictive modeling of COPD exacerbation rates using baseline risk factors
by: Dave Singh, et al.
Published: (2022-07-01)

Blood eosinophil count and exacerbation risk in patients with COPD.
by: Kerkhof, M, et al.
Published: (2017)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
by: Seung Won Ra, et al.
Published: (2017-05-01)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
by: Russell, R, et al.
Published: (2019)

The acute wheezy adult with airways disease in the emergency department: a retrospective case-note review of exacerbations of COPD
by: Russell REK, et al.
Published: (2019-05-01)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
by: Siva, R, et al.
Published: (2007)

Biomarkers in COPD
by: Ramakrishnan, S, et al.
Published: (2021)

Radiological diagnosis of copd exacerbations
by: N. A. Gorbunov, et al.
Published: (2013-11-01)

RADIOLOGICAL DIAGNOSIS OF COPD EXACERBATIONS
by: N. A. Gorbunov, et al.
Published: (2014-02-01)

COPD - is one exacerbation enough?
by: A J van den Berg
Published: (2023-09-01)

COPD exacerbation: Lost in translation
by: Bouros Demosthenes, et al.
Published: (2009-01-01)

Lung microbiology and exacerbations in COPD
by: Beasley V, et al.
Published: (2012-08-01)

Treatment of COPD exacerbations: antibiotics
by: R. Wilson
Published: (2005-09-01)

Exacerbation frequency and course of COPD
by: Halpin DMG, et al.
Published: (2012-09-01)

The airway microbiota and exacerbations of COPD
by: Elise Orvedal Leiten, et al.
Published: (2020-08-01)